SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

52,540.96 1,234.23
(2.41%)

Dow Jones

7,582.98 185.12
(2.50%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,779.79 105.85
(0.99%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

95.8112704

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

39.02

2776.12

EPS(TTM)

Face Value()

Div & Yield %

5.77

0.27

Back

CCL Products (India) consolidated net profit rises 29.00% in the September 2026 quarter

Oct 16,2026

Net profit of CCL Products (India) rose 29.00% to Rs 130.11 crore in the quarter ended September 2026 as against Rs 100.86 crore during the previous quarter ended September 2025. Sales rose 7.46% to Rs 1210.76 crore in the quarter ended September 2026 as against Rs 1126.73 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1210.76	1126.73	7
OPM %	17.52	17.50	-
PBDT	191.34	165.98	15
PBT	150.86	127.09	19
NP	130.11	100.86	29

81,106.65 107.25 ( 0.13%)

52,540.96 1,234.23 (2.41%)

7,582.98 185.12 (2.50%)

58,738.13 1,303.36 (2.27%)

10,779.79 105.85 (0.99%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)